\-\ Texto\\:\\ \ \(0\)\
\-\ general\\:\\ \\ appears\\ older\\ than\\ stated\\ age\\ and\\ chronically\\ ill\\.\ \(0\)\
\-\ abdomen\\:\\ normal\\ bowel\\ sounds\\ with\\ a\\ lobulated\\ mass\\ in\\ the\\ left\\ upper\\ quadrant\\.\ \(0\)\
\-\ neurologic\\:\\ cn\\ ii\\-\\ xii\\ intact\\.\\ \\ alert\\ and\\ oriented\\ x\\ 3\\.\ \(0\)\
\-\ prognosis\\ \\ and\\ \\ treatment\\:\\ multimodality\\ treatment\\ of\\ peritoneal\\ mesothelioma\\ has\\ become\\ more\\ common\\ in\\ recent\\ years\\,\\ since\\ surgery\\ alone\\ and\\/or\\ intraperitoneal\\ chemotherapy\\ alone\\ have\\ proven\\ to\\ be\\ similarly\\ ineffective\\.\\ debulking\\ surgery\\ involves\\ the\\ removal\\ of\\ all\\ or\\ nearly\\ all\\ visible\\ tumor\\,\\ andmay\\ be\\ combined\\ with\\ intraperitoneal\\ chemotherapy\\ and\\/or\\ radiation\\.\ \(0\)\
\-\ on\\ ct\\ imaging\\ the\\ mass\\ was\\ encasing\\ the\\ spleen\\ circumstantially\\.\\ the\\ mass\\ also\\ encased\\ the\\ perisplenic\\ vessels\\ and\\ splenic\\ hilar\\ vessels\\.\\ ir\\ was\\ consulted\\ and\\ a\\ ct\\ guided\\ biopsy\\ yielded\\ atypical\\ mesothelioma\\ cells\\.\\ \\ pet\\ examination\\ showed\\ hypermetabolic\\ activity\\ in\\ the\\ perisplenic\\ mass\\ as\\ well\\ as\\ within\\ portal\\ nodes\\ and\\ internal\\ mammary\\ nodes\\.\ \(0\)\
\-\ peritoneal\\ mesothelioma\ \(3\)\
\-\ \\â\\€\\¢\\ peritoneal\\ mesothelioma\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ peritoneal\\ carcinomatosis\ \(0\)\
\-\ 65\\-year\\-old\\ man\\ with\\ a\\ one\\ week\\ history\\ of\\ abdominal\\ pain\\ and\\ distention\\.\\ \\ past\\ medical\\ history\\ significant\\ for\\ dm2\\ and\\ smoking\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ mesothelioma\\:\\ 0\\.11954821276350328\ \(0\)\
\-\ peritoneal\\:\\ 0\\.09935353232401066\ \(0\)\
\-\ perisplenic\\:\\ 0\\.0830080900876716\ \(0\)\
\-\ intraperitoneal\\:\\ 0\\.05673574084562156\ \(0\)\
\-\ alone\\:\\ 0\\.051685627731173994\ \(0\)\
\-\ ii\\-\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ andmay\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ circumstantially\\:\\ 0\\.04924870627914245\ \(0\)\
\-\ nodes\\:\\ 0\\.04312504319961159\ \(0\)\
\-\ multimodality\\:\\ 0\\.043111207459767535\ \(0\)\
\-\ 65\\-year\\-old\\:\\ 0\\.0415040450438358\ \(0\)\
\-\ and\\/or\\:\\ 0\\.040352086445695004\ \(0\)\
\-\ encased\\:\\ 0\\.04025743302532066\ \(0\)\
\-\ dm2\\:\\ 0\\.03923887684211421\ \(0\)\
\-\ vessels\\:\\ 0\\.038438435936115456\ \(0\)\
\-\ xii\\:\\ 0\\.03837769985983902\ \(0\)\
\-\ ineffective\\:\\ 0\\.036973708640392615\ \(0\)\
\-\ chronically\\:\\ 0\\.03638510240766733\ \(0\)\
\-\ encasing\\:\\ 0\\.03585264330261524\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.03585264330261524\ \(0\)\
\-\ similarly\\:\\ 0\\.034505369242185696\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.034222857934534806\ \(0\)\
\-\ debulking\\:\\ 0\\.03375938380852914\ \(0\)\
\-\ ir\\:\\ 0\\.03375938380852914\ \(0\)\
\-\ mammary\\:\\ 0\\.03375938380852914\ \(0\)\
\-\ yielded\\:\\ 0\\.0334206987704485\ \(0\)\
\-\ ill\\:\\ 0\\.031047049642150926\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.02922904740508597\ \(0\)\
\-\ consulted\\:\\ 0\\.0290759805101803\ \(0\)\
\-\ guided\\:\\ 0\\.0290759805101803\ \(0\)\
\-\ proven\\:\\ 0\\.027174719024497602\ \(0\)\
\-\ all\\:\\ 0\\.027004731725489284\ \(0\)\
\-\ mass\\:\\ 0\\.026557787864750045\ \(0\)\
\-\ combined\\:\\ 0\\.026375272970639095\ \(0\)\
\-\ nearly\\:\\ 0\\.026282930501637918\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.026262810361942255\ \(0\)\
\-\ stated\\:\\ 0\\.02601472257322249\ \(0\)\
\-\ splenic\\:\\ 0\\.025842813865586997\ \(0\)\
\-\ cn\\:\\ 0\\.025676037535141853\ \(0\)\
\-\ spleen\\:\\ 0\\.025676037535141853\ \(0\)\
\-\ distention\\:\\ 0\\.025514095988363905\ \(0\)\
\-\ \\:\\:\\ 0\\.025257537787500894\ \(0\)\
\-\ portal\\:\\ 0\\.025128660952123957\ \(0\)\
\-\ pet\\:\\ 0\\.025054665271956243\ \(0\)\
\-\ smoking\\:\\ 0\\.024110104768917506\ \(0\)\
\-\ older\\:\\ 0\\.02404837384050083\ \(0\)\
\-\ lobulated\\:\\ 0\\.023987317580544457\ \(0\)\
\-\ hilar\\:\\ 0\\.023987317580544457\ \(0\)\
\-\ alert\\:\\ 0\\.023808053253441104\ \(0\)\
\-\ oriented\\:\\ 0\\.02341086933342026\ \(0\)\
\-\ surgery\\:\\ 0\\.0231843470878243\ \(0\)\
\-\ become\\:\\ 0\\.02274070556202932\ \(0\)\
\-\ prognosis\\:\\ 0\\.022644382621054424\ \(0\)\
\-\ visible\\:\\ 0\\.02259683686871974\ \(0\)\
\-\ involves\\:\\ 0\\.02218620858942965\ \(0\)\
\-\ atypical\\:\\ 0\\.02069011528273718\ \(0\)\
\-\ general\\:\\ 0\\.020114986962891133\ \(0\)\
\-\ neurologic\\:\\ 0\\.01993572263578778\ \(0\)\
\-\ treatment\\:\\ 0\\.01932532915755181\ \(0\)\
\-\ cells\\:\\ 0\\.019142160302513953\ \(0\)\
\-\ sounds\\:\\ 0\\.01904104275143229\ \(0\)\
\-\ removal\\:\\ 0\\.018820005878772\ \(0\)\
\-\ activity\\:\\ 0\\.017910875021125913\ \(0\)\
\-\ appears\\:\\ 0\\.017769434753057256\ \(0\)\
\-\ intact\\:\\ 0\\.017534997886582217\ \(0\)\
\-\ since\\:\\ 0\\.017534997886582217\ \(0\)\
\-\ biopsy\\:\\ 0\\.016936833752160676\ \(0\)\
\-\ quadrant\\:\\ 0\\.016800982871430472\ \(0\)\
\-\ 3\\.\\:\\ 0\\.01633449280525546\ \(0\)\
\-\ week\\:\\ 0\\.016212376638705187\ \(0\)\
\-\ recent\\:\\ 0\\.016048709770054733\ \(0\)\
\-\ internal\\:\\ 0\\.016004893136194253\ \(0\)\
\-\ x\\:\\ 0\\.0157489739404887\ \(0\)\
\-\ radiation\\:\\ 0\\.015666208098113612\ \(0\)\
\-\ showed\\:\\ 0\\.01565253222303741\ \(0\)\
\-\ past\\:\\ 0\\.015168712133778961\ \(0\)\
\-\ bowel\\:\\ 0\\.014971807446283571\ \(0\)\
\-\ examination\\:\\ 0\\.014840352153489191\ \(0\)\
\-\ be\\:\\ 0\\.014723538808312057\ \(0\)\
\-\ medical\\:\\ 0\\.014688881564614549\ \(0\)\
\-\ age\\:\\ 0\\.014530225282370428\ \(0\)\
\-\ as\\:\\ 0\\.014442206769766791\ \(0\)\
\-\ abdomen\\:\\ 0\\.014141811524556963\ \(0\)\
\-\ years\\:\\ 0\\.014018118083902137\ \(0\)\
\-\ lymphoma\\:\\ 0\\.013643567789885395\ \(0\)\
\-\ ct\\:\\ 0\\.013355348082592658\ \(0\)\
\-\ history\\:\\ 0\\.013186754611252328\ \(0\)\
\-\ one\\:\\ 0\\.012937046834137676\ \(0\)\
\-\ significant\\:\\ 0\\.012837134922090633\ \(0\)\
\-\ than\\:\\ 0\\.01250865282077248\ \(0\)\
\-\ common\\:\\ 0\\.012493112915957526\ \(0\)\
\-\ more\\:\\ 0\\.011939532454257912\ \(0\)\
\-\ abdominal\\:\\ 0\\.011932509710179414\ \(0\)\
\-\ upper\\:\\ 0\\.01152000282328893\ \(0\)\
\-\ man\\:\\ 0\\.01129012202843575\ \(0\)\
\-\ imaging\\:\\ 0\\.011184769969025713\ \(0\)\
\-\ tumor\\:\\ 0\\.011129789394473805\ \(0\)\
\-\ was\\:\\ 0\\.011042206952108233\ \(0\)\
\-\ well\\:\\ 0\\.01079933493278576\ \(0\)\
\-\ have\\:\\ 0\\.010337642895894368\ \(0\)\
\-\ also\\:\\ 0\\.009411282646201963\ \(0\)\
\-\ within\\:\\ 0\\.009106879376458557\ \(0\)\
\-\ has\\:\\ 0\\.008964804304437307\ \(0\)\
\-\ and\\:\\ 0\\.008045095228255573\ \(0\)\
\-\ normal\\:\\ 0\\.0074838684614474925\ \(0\)\
\-\ in\\:\\ 0\\.00706252341017187\ \(0\)\
\-\ a\\:\\ 0\\.00664692405282572\ \(0\)\
\-\ pain\\:\\ 0\\.005830213226428686\ \(0\)\
\-\ or\\:\\ 0\\.00559509915622183\ \(0\)\
\-\ the\\:\\ 0\\.005406396608521679\ \(0\)\
\-\ left\\:\\ 0\\.005341370219401759\ \(0\)\
\-\ for\\:\\ 0\\.0040732298806855595\ \(0\)\
\-\ on\\:\\ 0\\.004044083867963286\ \(0\)\
\-\ \\,\\:\\ 0\\.0030246934694668983\ \(0\)\
\-\ to\\:\\ 0\\.002385855354430091\ \(0\)\
\-\ \\.\\:\\ 0\\.0021815357378257485\ \(0\)\
\-\ with\\:\\ 0\\.0019609638450819506\ \(0\)\
\-\ of\\:\\ 0\\.0019525776670053926\ \(0\)\
